Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Int J Gen Med. 2011;4:461-4. doi: 10.2147/IJGM.S20107. Epub 2011 Jun 15.
Available evidence about the role of supplementary vitamin E in normal pregnancy is inadequate. This study assessed the potential benefit of vitamin E supplementation on some pregnancy health indices.
A 1:2 weighted simple randomization technique was used to allocate 104 eligible pregnant women to receive vitamin E and 168 women (control) not to receive the drug. Treated women received capsules containing 400 IU vitamin E from week 14 of gestation to the end of the pregnancy.
Background variables including maternal age were found to be similarly distributed between the study groups. The rate of maternal and perinatal outcomes including Apgar score and birth weight did not differ significantly between groups. Preeclampsia occurred in 1% of treated women vs 1.78% of control women.
Giving supplemental vitamin E from the second trimester of pregnancy did not appear to affect the risk of pregnancy outcomes and occurrence of preeclampsia.
关于补充维生素 E 在正常妊娠中的作用的现有证据不足。本研究评估了维生素 E 补充剂对一些妊娠健康指标的潜在益处。
采用 1:2 加权简单随机化技术将 104 名符合条件的孕妇分配为接受维生素 E 治疗组(n=104)和未接受药物治疗的对照组(n=168)。从妊娠第 14 周开始,治疗组孕妇服用含有 400IU 维生素 E 的胶囊,直至妊娠结束。
研究组之间的背景变量(包括母亲年龄)分布相似。两组间产妇和围产儿结局(包括阿普加评分和出生体重)的发生率无显著差异。治疗组子痫前期的发生率为 1%,对照组为 1.78%。
从妊娠中期开始补充维生素 E 似乎不会增加妊娠结局和子痫前期的发生风险。